51 – 60 of 4461
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Point of view : Challenges in implementation of new immunotherapies for Alzheimer's disease
- Contribution to journal › Article
-
Mark
Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease
- Contribution to journal › Article
-
Mark
Autologous cells, no longer lost in translation
- Contribution to journal › Debate/Note/Editorial
-
Mark
Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa-Induced Dyskinesia
- Contribution to journal › Article
-
Mark
Antisecretory factor in severe traumatic brain injury (AFISTBI) : protocol for an exploratory randomized placebo-controlled trial
- Contribution to journal › Article
-
Mark
TOR1AIP2 as a candidate gene for dystonia-hemichorea/hemiballism
- Contribution to journal › Article
-
Mark
GDNF overexpression in astrocytes enhances branching and partially preserves hippocampal function in an Alzheimer's rat model
- Contribution to journal › Article
-
Mark
TREM2 risk variants and associated endophenotypes in alzheimer’s disease
- Contribution to journal › Article
-
Mark
Disparate and shared transcriptomic signatures associated with cortical atrophy in genetic behavioral variant frontotemporal degeneration
- Contribution to journal › Article
-
Mark
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
- Contribution to journal › Scientific review
